Clearance and recycling of pulmonary surfactant
- PMID: 2200279
- DOI: 10.1152/ajplung.1990.259.2.L1
Clearance and recycling of pulmonary surfactant
Abstract
In a steady state the rate of secretion of pulmonary surfactant lipids and proteins into the alveolar airspace must be balanced by the rate of removal. Several potential pathways for clearance have been identified including uptake by alveolar type II cells, which also synthesize and secrete surfactant components, uptake by other epithelial cells, and internalization by alveolar macrophages. A small amount of surfactant moves up the airways and through the epithelium-endothelium barrier into the blood. Some of the surfactant lipids and proteins that are cleared from the alveolar airspace appear to be "recycled" in that they appear in the lamellar body, a surfactant secretory granule found in the type II cell. Some surfactant lipids are degraded, probably intracellularly, and the degradation products are reutilized to synthesize new lipids. Several factors have been shown to affect internalization by the type II cell and/or alveolar clearance including the surfactant proteins, lipids, and known stimuli of surfactant secretion. Surfactant proteins may be involved in regulating pool size by modulating both secretion rates and uptake rates, possibly by a receptor-mediated process, although such receptors have not yet been identified or isolated. Clearance of surfactant lipids from the alveolar airspace is more rapid than clearance from the whole lung, and these two processes may be regulated by different factors. Elucidation of the factors that fine tune the balance between synthesis, secretion, and clearance of the lipid and protein components of surfactant awaits further investigation.
Similar articles
-
Effect of endocytosis inhibitors on alveolar clearance of albumin, immunoglobulin G, and SP-A in rabbits.Am J Physiol. 1994 May;266(5 Pt 1):L544-52. doi: 10.1152/ajplung.1994.266.5.L544. Am J Physiol. 1994. PMID: 8203547
-
Alterations of surfactant lipid turnover in silicosis: evidence of a role for surfactant-associated protein A (SP-A).Int J Exp Pathol. 1995 Aug;76(4):287-98. Int J Exp Pathol. 1995. PMID: 7547443 Free PMC article.
-
Alveolar lipids in pulmonary disease. A review.Lipids Health Dis. 2020 Jun 3;19(1):122. doi: 10.1186/s12944-020-01278-8. Lipids Health Dis. 2020. PMID: 32493486 Free PMC article. Review.
-
Immunocytochemical localization of the major surfactant apoproteins in type II cells, Clara cells, and alveolar macrophages of rat lung.J Histochem Cytochem. 1986 Sep;34(9):1137-48. doi: 10.1177/34.9.2426341. J Histochem Cytochem. 1986. PMID: 2426341
-
Pulmonary surfactant: no mere paint on the alveolar wall.Respirology. 1996 Dec;1(4):247-57. doi: 10.1111/j.1440-1843.1996.tb00040.x. Respirology. 1996. PMID: 9441113 Review.
Cited by
-
Oral Supplementation with the Polyamine Spermidine Affects Hepatic but Not Pulmonary Lipid Metabolism in Lean but Not Obese Mice.Nutrients. 2022 Oct 15;14(20):4318. doi: 10.3390/nu14204318. Nutrients. 2022. PMID: 36297003 Free PMC article.
-
An intronic ABCA3 mutation that is responsible for respiratory disease.Pediatr Res. 2012 Jun;71(6):633-7. doi: 10.1038/pr.2012.21. Epub 2012 Feb 15. Pediatr Res. 2012. PMID: 22337229 Free PMC article.
-
In vivo clearance of surfactant lipids during acute pulmonary inflammation.Respir Res. 2004 Jul 23;5(1):8. doi: 10.1186/1465-9921-5-8. Respir Res. 2004. PMID: 15357882 Free PMC article.
-
The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis.Front Med (Lausanne). 2018 Mar 20;5:43. doi: 10.3389/fmed.2018.00043. eCollection 2018. Front Med (Lausanne). 2018. PMID: 29616220 Free PMC article. Review.
-
Current technology in the diagnosis of developmentally related lung disorders.Neonatology. 2012;101(4):353-9. doi: 10.1159/000337356. Epub 2012 Jun 1. Neonatology. 2012. PMID: 22940625 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources